Literature DB >> 13810513

Treatment of occlusive vascular disease with disodium ethylene diamine tetraacetic acid (EDTA).

N E CLARKE, N E CLARKE, R E MOSHER.   

Abstract

Entities:  

Keywords:  EDATHAMIL/therapy; VASCULAR DISEASES, PERIPHERAL/therapy

Mesh：

Substances：

Year:  1960        PMID： 13810513     DOI： 10.1097/00000441-196006000-00008

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN： 0002-9629            Impact factor:   2.378


× No keyword cloud information.
  6 in total

1.  Myocardial responses to chelation.

Authors:  A SOFFER; T TORIBARA; A SAYMAN
Journal:  Br Heart J       Date:  1961-11

Review 2.  Chelation therapy for cardiovascular disease. Review and commentary.

Authors:  M R Lewin
Journal:  Tex Heart Inst J       Date:  1997

3.  A pilot double-blind study of sodium-magnesium EDTA in peripheral vascular disease.

Authors:  E Olszewer; F C Sabbag; J P Carter
Journal:  J Natl Med Assoc       Date:  1990-03       Impact factor: 1.798

4.  Why the NIH Trial to Assess Chelation Therapy (TACT) should be abandoned.

Authors:  Kimball C Atwood; Elizabeth Woeckner; Robert S Baratz; Wallace I Sampson
Journal:  Medscape J Med       Date:  2008-05-13

Review 5.  A TACTful reappraisal of chelation therapy in cardiovascular disease.

Authors:  Mandeep S Sidhu; Basil M Saour; William E Boden
Journal:  Nat Rev Cardiol       Date:  2013-12-17       Impact factor: 32.419

Review 6.  Chelation Therapy in Patients With Cardiovascular Disease: A Systematic Review.

Authors:  Filippo Ravalli; Xavier Vela Parada; Francisco Ujueta; Rachel Pinotti; Kevin J Anstrom; Gervasio A Lamas; Ana Navas-Acien
Journal:  J Am Heart Assoc       Date:  2022-03-01       Impact factor: 6.106
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.